HOWARD PHD BERNSTEIN MD

Insider Reports History

Signature
/s/ Lawrence Knopf, Attorney in Fact for Howard Bernstein
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by HOWARD PHD BERNSTEIN MD:

Company Role Class Num Shares Value Price $ Report Date Ownership
SQZ Biotechnologies Co Interim Chief Executive Office, Director Stock Option 830,000 24 Jan 2023 Direct

Insider Reports Filed by HOWARD PHD BERNSTEIN MD

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000120919123005067-bernstein-howard-phd-md-2023-01-24 SQZ Biotechnologies Co 24 Jan 2023 1 $0 4 Interim Chief Executive Office, Director 26 Jan 2023, 15:40
/report/000120919122009830-bernstein-howard-phd-md-2022-02-10 SQZ Biotechnologies Co 10 Feb 2022 1 $0 4 Chief Scientific Officer 15 Feb 2022, 16:15